These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12638156)

  • 1. [Efficacy and safety of twice-daily administration of CTDR].
    Ogata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():98. PubMed ID: 12638156
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isolation of bacteria and treatment of patients with pneumococcal and Haemophilus influenzae infections].
    Suzuki K
    Jpn J Antibiot; 2001 May; 54 Suppl B():97. PubMed ID: 12638155
    [No Abstract]   [Full Text] [Related]  

  • 3. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
    Sakata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Yokoyama M
    Jpn J Antibiot; 2001 May; 54 Suppl B():88-90. PubMed ID: 12638152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiological study of pneumococcal infections and Haemophilus influenzae infections in the last three years].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():72-9. PubMed ID: 12638146
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies.
    Ginsburg AS; Tinkham L; Riley K; Kay NA; Klugman KP; Gill CJ
    Int J Antimicrob Agents; 2013 Dec; 42(6):482-91. PubMed ID: 24139883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological study of pneumococcal infection and Haemophilus influenzae infection].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():4-10. PubMed ID: 12638134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical isolates and treatment of acute otitis media].
    Kataoka S
    Jpn J Antibiot; 2001 May; 54 Suppl B():30-3. PubMed ID: 12638139
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I; Tillotson G
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present status of pneumococcal infection and Haemophilus influenzae infection in Fukushima Prefecture, Japan].
    Suzuki T
    Jpn J Antibiot; 2001 May; 54 Suppl B():83. PubMed ID: 12638150
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are cephalosporins appropriate for the treatment of acute otitis media in this era of increasing antimicrobial resistance among common respiratory tract pathogens?
    Appelbaum PC
    Clin Pediatr (Phila); 2005 Mar; 44(2):95-107. PubMed ID: 15735827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y; Kanemura H; Kitano M; Mitsui Y; Ishihara T; Hoshiai M; Ohno R
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is Streptococcus pneumoniae and Haemophilus influenzae resistance reversible?].
    Aubry-Damon H
    Rev Pneumol Clin; 2000 Oct; Suppl 1():1S21-3. PubMed ID: 11103986
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of garenoxacin tablets on bacterial pneumonia: postmarketing surveillance in Japan.
    Izumikawa K; Watanabe A; Miyashita N; Ishida T; Hosono H; Kushimoto S; Kohno S
    J Infect Chemother; 2014 Sep; 20(9):549-57. PubMed ID: 24934887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Centers for Disease Control and Prevention. Antibiotic resistance among nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae--Bangui, 1995.
    JAMA; 1997 Feb; 277(8):621. PubMed ID: 9039868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.